Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $8.25B.
ENTERPRISE VALUE (EV)
$8.25B
HealthEquity, Inc.
Market Cap
$7.61B
Enterprise Value (EV)
$8.25B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| HealthEquity, Inc. (HQY) | $7.61B | $8.25B |
| Cytokinetics, Incorporated (CYTK)vs › | $7.62B | $8.64B |
| Hinge Health, Inc. (HNGE)vs › | $7.56B | $7.28B |
| Praxis Precision Medicines, Inc. (PRAX)vs › | $7.68B | $7.20B |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.32B | $9.39B |
| Caris Life Sciences, Inc. (CAI)vs › | $7.93B | $7.69B |
| TG Therapeutics, Inc. (TGTX)vs › | $7.95B | $8.22B |
| Alkermes plc (ALKS)vs › | $7.00B | $8.06B |
| Oscar Health, Inc. (OSCR)vs › | $8.36B | $4.71B |
| Chemed Corporation (CHE)vs › | $6.66B | $6.95B |
Market Cap
$7.61B
Total Debt
$957.38M
Cash
$318.93M
Enterprise Value
$8.25B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute